GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
96.26
-1.90 (-1.94%)
At close: Jan 30, 2026, 4:00 PM EST
96.00
-0.26 (-0.27%)
After-hours: Jan 30, 2026, 6:50 PM EST
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $2.78 billion as of January 30, 2026. Its market cap has increased by 39.87% in one year.
Market Cap
2.78B
Enterprise Value
2.74B
1-Year Change
39.87%
Ranking
Category
Stock Price
$96.26
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $2.78B, a decrease of -84.45%. That is a compound annual growth rate of -29.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 2.78B | -25.99% |
| Dec 31, 2025 | 3.76B | 78.04% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RadNet | 5.49B |
| Sotera Health Company | 5.14B |
| GRAIL | 3.85B |
| BillionToOne | 3.83B |
| Veracyte | 3.02B |
| Twist Bioscience | 2.53B |
| Neogen | 2.23B |
| NeoGenomics | 1.56B |